SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs

R Rasizadeh, PS Aghbash, JS Nahand… - Virology journal, 2023 - Springer
SARS-CoV-2 has been responsible for the recent pandemic all over the world, which has
caused many complications. One of the hallmarks of SARS-CoV-2 infection is an induced …

Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders

P Sadeghi, PS Pezeshki, N Rezaei - European Journal of Pediatrics, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) infection in pediatric patients with
autoimmune disorders is an area of particular concern since autoimmune diseases can …

LCCNN: a lightweight customized CNN-based distance education app for COVID-19 recognition

J Wang, SC Satapathy, S Wang, Y Zhang - Mobile Networks and …, 2023 - Springer
In the global epidemic, distance learning occupies an increasingly important place in
teaching and learning because of its great potential. This paper proposes a web-based app …

PBMC MicroRNAs: Promising biomarkers for the differential diagnosis of COVID-19 patients with abnormal coagulation indices

AKA Kasho, JS Nahand, A Salmaninejad, H Mirzaei… - Current …, 2023 - Springer
MicroRNAs, or miRNAs, may involve in coagulation and inflammation pathways caused by
severe Coronavirus disease (COVID-19). Accordingly, this attempt was made to explore the …

SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis

HY Jeong, JS Park, JS Woo, KH Lee, JW Choi… - Journal of …, 2023 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) induces a dysfunctional
immune response, inflammation, autoantibody production, and coagulopathy, which are …

[HTML][HTML] Beyond the virus: exploring coinfections in the COVID-19 pandemic

R Rasizadeh, ES Milani… - The Open …, 2023 - openmicrobiologyjournal.com
The global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
responsible for the COVID-19 pandemic, cannot be understated. Amidst the relentless focus …

Design and fabrication strategies of molybdenum disulfide-based nanomaterials for combating SARS-CoV-2 and other respiratory diseases: A review

EP Silva, F Rechotnek, AMO Lima, ACP da Silva… - Biomaterials …, 2024 - Elsevier
Abstract The coronavirus disease (COVID-19) pandemic underscored the critical need for
innovative technologies to combat infectious diseases. Given the need for knowledge and …

Adaptive Stacking Ensemble Techniques for Early Severity Classification of COVID-19 Patients

GW Kim, CY Ju, H Seok, DH Lee - Applied Sciences, 2024 - mdpi.com
During outbreaks of infectious diseases, such as COVID-19, it is critical to rapidly determine
treatment priorities and identify patients requiring hospitalization based on clinical severity …

Impact of COVID-19 pandemic on the incidence and severity of myasthenia gravis in Korea: using National Health Insurance Service database

S Kim, EK Lee, H Kim, H Kim, E Sohn - Frontiers in Neurology, 2024 - frontiersin.org
Background This study investigated the impact of COVID-19 pandemic on the incidence and
severity of myasthenia gravis (MG) using the National Health Insurance Service (NHIS) …

[PDF][PDF] Exploring Nature's Invigorating Power: Phytotherapy for SARS-CoV-2

F Bashir, A Komal, A Ibrahim, QT Ain… - …, 2023 - researchgate.net
Covid-19 is a respiratory disease caused by the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) that spreads by person-to-person contact. The virus is thought …